$SBIG
springbig Holdings Inc

2022 Q1 Form 10-Q Financial Statement

#000114036122019421 Filed on May 16, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021 Q1
Revenue $6.364M $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue $1.843M $1.619M $1.590M
YoY Change 15.91% 7.22%
Gross Profit $4.521M $4.980M $3.620M
YoY Change 24.89% 55.63%
Gross Profit Margin 71.04%
Selling, General & Admin $4.570M $4.360M $3.180M
YoY Change 43.71% 54.06%
% of Gross Profit 101.08% 87.55% 87.85%
Research & Development $2.637M $2.760M $1.550M
YoY Change 70.13% 84.0%
% of Gross Profit 58.33% 55.42% 42.82%
Depreciation & Amortization $75.00K $173.0K $10.00K
YoY Change 650.0% 1630.0%
% of Gross Profit 1.66% 3.47% 0.28%
Operating Expenses $911.8K $1.499M $95.58K
YoY Change 854.02% -65.47% 1802.05%
Operating Profit -$911.8K $3.481M -$95.58K
YoY Change 854.02% -405.38% 1802.05%
Interest Expense -$93.00K $3.280K $5.790K
YoY Change -1706.22%
% of Operating Profit 0.09%
Other Income/Expense, Net $4.164M $320.0K -$1.968M
YoY Change -311.65%
Pretax Income -$2.865M -$1.175M -$2.063M
YoY Change 38.86% 4.01%
Income Tax $0.00 $2.000K $0.00
% Of Pretax Income
Net Earnings $3.253M -$1.175M -$2.063M
YoY Change -257.65% 4.01%
Net Earnings / Revenue 51.11%
Basic Earnings Per Share -$0.21
Diluted Earnings Per Share -$151.3K -$21.54K -$41.82K
COMMON SHARES
Basic Shares Outstanding 13.57M shares
Diluted Shares Outstanding 13.57M shares

Balance Sheet

Concept 2022 Q1 2021 Q4 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $416.6K $621.5K $814.0K
YoY Change -48.82%
Cash & Equivalents $6.761M $621.5K $814.0K
Short-Term Investments
Other Short-Term Assets $249.7K $259.9K $495.4K
YoY Change -49.6%
Inventory
Prepaid Expenses $259.9K $495.4K
Receivables $2.950M $3.045M
Other Receivables $0.00 $0.00
Total Short-Term Assets $666.3K $881.4K $1.309M
YoY Change -49.12% 374.51%
LONG-TERM ASSETS
Property, Plant & Equipment $500.0K $480.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $200.0M
YoY Change
Other Assets $200.0M $200.0M
YoY Change
Total Long-Term Assets $200.0M $200.0M $200.0M
YoY Change 0.02% 47860.67%
TOTAL ASSETS
Total Short-Term Assets $666.3K $881.4K $1.309M
Total Long-Term Assets $200.0M $200.0M $200.0M
Total Assets $200.7M $200.9M $201.3M
YoY Change -0.3% 33228.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.252M $412.0K $43.96K
YoY Change 5023.09%
Accrued Expenses $108.0K $108.0K $108.0K
YoY Change 0.0%
Deferred Revenue $450.0K
YoY Change -19.64%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $2.360M $1.663M $152.0K
YoY Change 1453.07% 185.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $12.28M $16.44M $28.12M
YoY Change -56.34%
Total Long-Term Liabilities $12.28M $16.44M $28.12M
YoY Change -56.34%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.360M $1.663M $152.0K
Total Long-Term Liabilities $12.28M $16.44M $28.12M
Total Liabilities $14.64M $18.10M $28.27M
YoY Change -48.22% 3005.75%
SHAREHOLDERS EQUITY
Retained Earnings -$17.19M -$28.15M
YoY Change 339289.49%
Common Stock $2.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.93M -$17.19M -$26.96M
YoY Change
Total Liabilities & Shareholders Equity $200.7M $200.9M $201.3M
YoY Change -0.3% 33228.73%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021 Q1
OPERATING ACTIVITIES
Net Income $3.253M -$1.175M -$2.063M
YoY Change -257.65% 4.01%
Depreciation, Depletion And Amortization $75.00K $173.0K $10.00K
YoY Change 650.0% 1630.0%
Cash From Operating Activities -$204.9K -$103.0K -$547.0K
YoY Change -62.55% -90.81% 2188048.0%
INVESTING ACTIVITIES
Capital Expenditures $73.00K $252.0K $40.00K
YoY Change 82.5% 404.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$200.0M
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 -$200.0M
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 201.2M
YoY Change -100.0% -100.0% 92618.21%
NET CHANGE
Cash From Operating Activities -204.9K -103.0K -547.0K
Cash From Investing Activities 0.000 0.000 -200.0M
Cash From Financing Activities 0.000 0.000 201.2M
Net Change In Cash -204.9K -103.0K 628.3K
YoY Change -132.61% -91.05% 189.6%
FREE CASH FLOW
Cash From Operating Activities -$204.9K -$103.0K -$547.0K
Capital Expenditures $73.00K $252.0K $40.00K
Free Cash Flow -$277.9K -$355.0K -$587.0K
YoY Change -52.66% -69.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001801602
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-40049
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
TUATARA CAPITAL ACQUISITION CORP
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
655 Third Avenue,
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
8th Floor
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
CY2022Q1 dei City Area Code
CityAreaCode
917
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
460-7522
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
true
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
20000000
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
20000000
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
20000000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
911834
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
95578
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-911834
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-95578
CY2022Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
4161600
CY2021Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1280000
CY2022Q1 tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
0
CY2021Q1 tcac Transaction Costs Allocated To Warrant Liabilities
TransactionCostsAllocatedToWarrantLiabilities
853386
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2400000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2794
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
5788
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4164394
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1967598
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3252560
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2063176
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-17186184
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3252560
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-13933624
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
19936
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0
CY2021Q1 tcac Redeemable Ordinary Shares Accretion To Redemption Value
RedeemableOrdinarySharesAccretionToRedemptionValue
24913470
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2063176
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-26956710
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
0
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2400000
CY2022Q1 tcac Proceeds From Issuance Initial Public Offering Net Of Offering Costs
ProceedsFromIssuanceInitialPublicOfferingNetOfOfferingCosts
0
CY2021Q1 tcac Proceeds From Issuance Initial Public Offering Net Of Offering Costs
ProceedsFromIssuanceInitialPublicOfferingNetOfOfferingCosts
196000000
CY2022Q1 us-gaap Cash
Cash
416588
CY2022Q1 tcac Working Capital
WorkingCapital
1693828
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div> <div style="text-align: justify; font-style: italic; font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Use of Estimates</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="display:none;"><br/></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-indent: 18pt;">The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman'; text-indent: 18pt; text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed consolidated financial statements is the determination of the fair value of the warrant liability. Accordingly, the actual results could differ significantly from those estimates.</span></div>
CY2022Q1 us-gaap Derivatives Methods Of Accounting Nonhedging Derivatives
DerivativesMethodsOfAccountingNonhedgingDerivatives
<div style="display:none;"><br/></div> <div style="letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: bold; text-align: left; text-indent: 0px; text-transform: none;">Warrant Liabilities</div> <div style="display:none;"><br/></div> <div style="letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 0px; text-transform: none;"><br/> </div> <div style="display:none;"><br/></div> <div style="letter-spacing: normal; white-space: normal; word-spacing: 0px; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-indent: 16.2pt; text-transform: none;">The Company accounts for the Warrants in accordance with the guidance contained in ASC 815-40 under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjust the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The Private Warrants and Public Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation model, specifically a binomial lattice. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date for both Public Warrants and Private Placement Warrants.</div>
CY2022Q1 tcac Option For Underwriters To Purchase Additional Units Term
OptionForUnderwritersToPurchaseAdditionalUnitsTerm
P45D
CY2021Q1 tcac Additional Units That Can Be Purchased To Cover Over Allotments
AdditionalUnitsThatCanBePurchasedToCoverOverAllotments
2625000
CY2021Q1 tcac Deferred Underwriting Commissions Per Unit
DeferredUnderwritingCommissionsPerUnit
0.35
CY2021Q1 tcac Deferred Underwriting Commissions
DeferredUnderwritingCommissions
7000000
CY2021Q2 tcac Number Of Underwriters Participating In Ipo
NumberOfUnderwritersParticipatingInIPO
1
CY2021Q2 tcac Underwriting Fees Deferred Waived
UnderwritingFeesDeferredWaived
4200000
CY2021Q3 us-gaap Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current And Noncurrent
AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrentAndNoncurrent
5000000
CY2021Q3 tcac Advisory Fee Payable Cash
AdvisoryFeePayableCash
2000000
CY2022Q1 tcac Percentage Of Non Refundable Cash Fees
PercentageOfNonRefundableCashFees
0.04
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
20000000
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
20000000
CY2022Q1 tcac Stock Conversion Ratio
StockConversionRatio
1
CY2022Q1 tcac Stock Conversion As Converted Percentage
StockConversionAsConvertedPercentage
0.20
CY2022Q1 tcac Period To Exercise Warrants After Business Combination
PeriodToExerciseWarrantsAfterBusinessCombination
P30D
CY2022Q1 tcac Period To Exercise Warrants After Closing Of Initial Public Offering
PeriodToExerciseWarrantsAfterClosingOfInitialPublicOffering
P12M
CY2022Q1 tcac Period To File Registration Statement After Initial Business Combination
PeriodToFileRegistrationStatementAfterInitialBusinessCombination
P15D
CY2022Q1 tcac Period For Registration Statement To Become Effective
PeriodForRegistrationStatementToBecomeEffective
P60D
CY2022Q1 tcac Trading Day Period To Calculate Volume Weighted Average Trading Price Following Notice Of Redemption
TradingDayPeriodToCalculateVolumeWeightedAverageTradingPriceFollowingNoticeOfRedemption
P10D
CY2022Q1 tcac Class Of Warrant Or Right Threshold Trigger Price For Redemption
ClassOfWarrantOrRightThresholdTriggerPriceForRedemption
10.00
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2022Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 tcac Number Of Underwriters Participating In Ipo
NumberOfUnderwritersParticipatingInIPO
1
CY2021Q2 tcac Underwriting Fees Deferred Waived
UnderwritingFeesDeferredWaived
4200000

Files In Submission

Name View Source Status
0001140361-22-019421-index-headers.html Edgar Link pending
0001140361-22-019421-index.html Edgar Link pending
0001140361-22-019421.txt Edgar Link pending
0001140361-22-019421-xbrl.zip Edgar Link pending
brhc10037384_10q.htm Edgar Link pending
brhc10037384_10q_htm.xml Edgar Link completed
brhc10037384_ex31-1.htm Edgar Link pending
brhc10037384_ex31-2.htm Edgar Link pending
brhc10037384_ex32-1.htm Edgar Link pending
brhc10037384_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tcac-20220331.xsd Edgar Link pending
tcac-20220331_cal.xml Edgar Link unprocessable
tcac-20220331_def.xml Edgar Link unprocessable
tcac-20220331_lab.xml Edgar Link unprocessable
tcac-20220331_pre.xml Edgar Link unprocessable